Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases.
Yamanaka K, Nakanishi T, Saito H, Maruyama J, Isoda K, Yokochi A, Imanaka-Yoshida K, Tsuda K, Kakeda M, Okamoto R, Fujita S, Iwakura Y, Suzuki N, Ito M, Maruyama K, Gabazza EC, Yoshida T, Shimaoka M, Mizutani H.
Yamanaka K, et al.
PLoS One. 2014 Aug 13;9(8):e104479. doi: 10.1371/journal.pone.0104479. eCollection 2014.
PLoS One. 2014.
PMID: 25119884
Free PMC article.